Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence. / Ishengoma, Deus S; Lwitiho, Sudi; Madebe, Rashid A; Nyagonde, Nyagonde; Persson, Ola; Vestergaard, Lasse S; Bygbjerg, Ib C; Lemnge, Martha M; Alifrangis, Michael.
In: Malaria Journal, Vol. 10, No. 1, 01.01.2011, p. 6.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence
AU - Ishengoma, Deus S
AU - Lwitiho, Sudi
AU - Madebe, Rashid A
AU - Nyagonde, Nyagonde
AU - Persson, Ola
AU - Vestergaard, Lasse S
AU - Bygbjerg, Ib C
AU - Lemnge, Martha M
AU - Alifrangis, Michael
PY - 2011/1/1
Y1 - 2011/1/1
N2 - Malaria prevalence has recently declined markedly in many parts of Tanzania and other sub-Saharan African countries due to scaling-up of control interventions including more efficient treatment regimens (e.g. artemisinin-based combination therapy) and insecticide-treated bed nets. Although continued molecular surveillance of malaria parasites is important to early identify emerging anti-malarial drug resistance, it is becoming increasingly difficult to obtain parasite samples from ongoing studies, such as routine drug efficacy trials. To explore other sources of parasite DNA, this study was conducted to examine if sufficient DNA could be successfully extracted from malaria rapid diagnostic tests (RDTs), used and collected as part of routine case management services in health facilities, and thus forming the basis for molecular analyses, surveillance and quality control (QC) testing of RDTs.
AB - Malaria prevalence has recently declined markedly in many parts of Tanzania and other sub-Saharan African countries due to scaling-up of control interventions including more efficient treatment regimens (e.g. artemisinin-based combination therapy) and insecticide-treated bed nets. Although continued molecular surveillance of malaria parasites is important to early identify emerging anti-malarial drug resistance, it is becoming increasingly difficult to obtain parasite samples from ongoing studies, such as routine drug efficacy trials. To explore other sources of parasite DNA, this study was conducted to examine if sufficient DNA could be successfully extracted from malaria rapid diagnostic tests (RDTs), used and collected as part of routine case management services in health facilities, and thus forming the basis for molecular analyses, surveillance and quality control (QC) testing of RDTs.
U2 - 10.1186/1475-2875-10-6
DO - 10.1186/1475-2875-10-6
M3 - Journal article
C2 - 21226910
VL - 10
SP - 6
JO - Malaria Journal
JF - Malaria Journal
SN - 1475-2875
IS - 1
ER -
ID: 33085871